274 related articles for article (PubMed ID: 21532837)
1. Clinical proteomics of breast cancer.
Baskın Y; Yiğitbaşı T
Curr Genomics; 2010 Nov; 11(7):528-36. PubMed ID: 21532837
[TBL] [Abstract][Full Text] [Related]
2. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
3. A systems approach to clinical oncology: focus on breast cancer.
Abramovitz M; Leyland-Jones B
Proteome Sci; 2006 Apr; 4():5. PubMed ID: 16595007
[TBL] [Abstract][Full Text] [Related]
4. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer proteomics: a review for clinicians.
Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
[TBL] [Abstract][Full Text] [Related]
6. Implications of functional proteomics in breast cancer.
Chae YK; Gonzalez-Angulo AM
Oncologist; 2014 Apr; 19(4):328-35. PubMed ID: 24664486
[TBL] [Abstract][Full Text] [Related]
7. Proteomic approach to breast cancer.
Laronga C; Drake RR
Cancer Control; 2007 Oct; 14(4):360-8. PubMed ID: 17914336
[TBL] [Abstract][Full Text] [Related]
8. Proteomics of breast cancer: principles and potential clinical applications.
Bertucci F; Birnbaum D; Goncalves A
Mol Cell Proteomics; 2006 Oct; 5(10):1772-86. PubMed ID: 16733261
[TBL] [Abstract][Full Text] [Related]
9. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
[TBL] [Abstract][Full Text] [Related]
10. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
11. Clinical proteomics and breast cancer.
Zeidan BA; Townsend PA; Garbis SD; Copson E; Cutress RI
Surgeon; 2015 Oct; 13(5):271-8. PubMed ID: 25736469
[TBL] [Abstract][Full Text] [Related]
12. [Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology].
Espejel F; Roa JC
Med Clin (Barc); 2008 Sep; 131(8):312-7. PubMed ID: 18803927
[TBL] [Abstract][Full Text] [Related]
13. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
Seibert V; Ebert MP; Buschmann T
Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
[TBL] [Abstract][Full Text] [Related]
14. Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum.
Lebrecht A; Boehm D; Schmidt M; Koelbl H; Grus FH
Cancer Genomics Proteomics; 2009; 6(2):75-83. PubMed ID: 19451091
[TBL] [Abstract][Full Text] [Related]
15. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
[TBL] [Abstract][Full Text] [Related]
16. SELDI-TOF serum proteomics and breast cancer: which perspective?
Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
[TBL] [Abstract][Full Text] [Related]
17. [Mass spectrometry imaging technology and its application in breast cancer research].
Zhang M; Zhang Y; Wang H; Li N; Li B; Xiao H; Bian W; Cai Z
Se Pu; 2021 Jun; 39(6):578-587. PubMed ID: 34227318
[TBL] [Abstract][Full Text] [Related]
18. Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry Imaging in the Study of Gastric Cancer: A Mini Review.
Smith A; Piga I; Galli M; Stella M; Denti V; Del Puppo M; Magni F
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194417
[TBL] [Abstract][Full Text] [Related]
19. SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
Zeidan BA; Townsend PA
Breast Cancer Res; 2008; 10(3):107. PubMed ID: 18644101
[TBL] [Abstract][Full Text] [Related]
20. Early diagnostic protein biomarkers for breast cancer: how far have we come?
Opstal-van Winden AW; Vermeulen RC; Peeters PH; Beijnen JH; van Gils CH
Breast Cancer Res Treat; 2012 Jul; 134(1):1-12. PubMed ID: 22179926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
